Canada Pension Plan Investment Board’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474K Sell
135,000
-53,000
-28% -$217K ﹤0.01% 1254
2025
Q4
$634K Buy
+188,000
New +$488K ﹤0.01% 1210
2022
Q3
Sell
-88,800
Closed -$1.02M 1257
2022
Q2
$1.02M Buy
+88,800
New +$1.05M ﹤0.01% 810
2022
Q1
Sell
-296,370
Closed -$3.46M 1449
2021
Q4
$3.46M Buy
+296,370
New +$3.64M ﹤0.01% 770
2020
Q3
Sell
-339,907
Closed -$3.51M 1228
2020
Q2
$3.51M Buy
+339,907
New +$3.48M 0.01% 606
2020
Q1
Sell
-53,307
Closed -$710K 1388
2019
Q4
$710K Buy
53,307
+10,807
+25% +$119K ﹤0.01% 1108
2019
Q3
$365K Sell
42,500
-88,100
-67% -$856K ﹤0.01% 1071
2019
Q2
$1.43M Sell
130,600
-475,474
-78% -$5.33M ﹤0.01% 994
2019
Q1
$6.87M Buy
606,074
+131,817
+28% +$1.47M 0.01% 698
2018
Q4
$4.12M Buy
+474,257
New +$5.44M 0.01% 821

Other funds holding IRWD

Canada Pension Plan Investment Board's IRWD Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Ironwood Pharmaceuticals (IRWD) stake by 28% in Q1 2026, selling an estimated $217K and leaving 135,000 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Canada Pension Plan Investment Board first reported a position in IRWD in Q4 2018 and has held it in 10 quarters since. The position peaked at $6.87M in Q1 2019. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Canada Pension Plan Investment Board held 135,000 shares of Ironwood Pharmaceuticals worth $474K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 53,000 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $217K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1254 holding.
  • Canada Pension Plan Investment Board first reported a position in Ironwood Pharmaceuticals in Q4 2018 and has held it in 10 quarters since.
  • Canada Pension Plan Investment Board's Ironwood Pharmaceuticals position peaked at $6.87M in Q1 2019.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.